MedPath

TEMBEXA

TEMBEXA

Approved
DIN Number

02543850

Drug Class

Human

Market Date

N/A

Company
HC

Emergent Biodefense Operations Lansing LLC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02543850
AIG Number0165482002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription Recommended
A
ATC Code
J05AB17 BRINCIDOFOVIR
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification08:18.32
Health Canada Classification

ACTIVE INGREDIENTS (1)

BRINCIDOFOVIRActive
Strength: 10 MG / ML
Monograph: BRINCIDOFOVIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.